CREATIVE WAYSAccording to source, Pinterest has recently seen the highest searches ever around mental wellness ideas including meditation (+44%), gratitude (+60%) and positivity (+42%) that jumped from February to May. Pinners are looking for creative ways to navigate and cope with their “new normal,” so they took a closer look at their shifting priorities to understand which trends would live out the remainder of 2020.
MRNA
$MRNA will run to $78.5, then $65I will be picking up puts at 78.5, 78-80 strike price with Friday expiry. ER aside this chart is setting up well from a short from the fib at $78.5. Additionally, RSI has not been below 40 at all this year. I also saw that the CMO dumped shares last week near the ath.
Moderna Stock Analysis - MRNAThe trend is bullish - the idea is to invest in the trend direction - wait the end of the price retracement before going long.
Moderna (MRNA) – Moderna is aiming to price its Covid-19 vaccine at $50 to $60 per dose, according to sources cited by the Financial Times. That would be at least $11 more than the vaccine being developed by Pfizer (PFE) and partner BioNTech (BNTX).
LONG $AZN Covid wave 2 play ($MRNA $GILD $INO $SPY)see full chart at www.tradingview.com
AZN
Entry $54 area
Target $57
stoploss 53
Why this play?
Covid Vaccine stocks are hot right now, cases are rising = easy money.
What is AZN?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,
cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
The company serves primary care and specialty care physicians through distributors and local representative offices.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
Analysis on Moderna (Vaccine Company)Moderna (MRNA) is developing a COVID-19 vaccine candidate that is widely considered one of the frontrunners to bring a vaccine to market; it was the first company to share data about how its experimental vaccine performed in a Phase 1 clinical trial. It has so far soared more than 350% since the start of the year. The main reason is that there has been tremendous widespread investor interest on their vaccination project, and the obvious unmet need/opportunity for a COVID-19 vaccine. However, J.P. Morgan just recently downgraded the rating on Moderna (MRNA) and signal that its currently overvalued. I feel that if the price dips or there's any pullback, would be a good opportunity to enter for a short hold and probably selling it upon the next peak which I believe would be around their Phase 3 trials. Because long term hold on Moderna might be risky since more often than not, vaccines usually takes a long time before it actually gets released and for the company to be actually profitable.
Moderna, Inc. (MRNA) short.All description on the chart.
Please, don't forget to like and follow.
Thank you.
MODERNA PUMP AND DUMP SCAMAnother bullshit "vaccine news" to suck in the gullible bulls.
2 Ellipses drawn above were pops, pump and dumps on supposed "good" vaccine news.
Insiders (including CFO and CEO) have been dumping stock non-stop. If their "vaccine" is so game changing why are they dumping?
Look at candle pattern on day of "vaccine news". We have formed an identical pattern.
Open is being used to sell to gullible "investors."
S&P 500 response to every vaccine news from this company or Pfizer etc is having less and less durable impact and gains being reversed quickly.
S&P wants to go down.
As soon as S&P gets down to critical levels and bears look like about to take over a new bullshit "Vaccine" news comes out.
S&P is top heavy and wants to go down.
Stay short and sell rallies.
Cheers!
Cyrus
Moderna Stock Analysis - MRNAThe market is Bullish and the idea, if it is possible, is to invest always in the trend direction. Stochastic is on overbought meaning that the prices might be ready to start the retracement stage.
Based on Technical analysis, the idea is to hold and wait the end of the price retracement before going long.
Fundametal Analysis
Moderna — Moderna shares jumped 10% after the data released by the New England Journal of Medicine showed the company’s coronavirus vaccine candidate, produced neutralizing antibodies in all 45 patients in its early stage human trial. The data shows the vaccine “elicits a robust immune response across all dose levels,” Moderna Chief Medical Officer Tal Zaks said in a statement.
$MRNA road to lazy 5?New positive updates came out regarding their phase one vaccine trial
Projected 4 broke down but managed to bounce back
Moderna, Inc. (MRNA) short.All description on the chart.
Please, don't forget to like and follow.
Thank you.
$AZN Covid wave 2 play ($MRNA $GILD $INO $SPY)see full chart at www.tradingview.com
AZN
Entry $51.68
Target $53
stoploss $50
Why this play?
they are really trying to push the Covid wave 2 case, and the market is crash. so if wave 2 really comes, these stocks should pump even further.
What is AZN?
AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology,
cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide.
The company serves primary care and specialty care physicians through distributors and local representative offices.
The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999.
STOCKS TO HEDGE TSLA WITH: MRNA?I like biotech's potential from here and it shows up as a low to medium distance return on TSLA puts in my data experiments
Could be reversal pattern on the spy weekly.see charts at www.tradingview.com
on june 15th, we called the make or break on spy(see here )
it Held the $300 line so it bounced off perfectly.
However, i just peaked at the Weekly chart and saw that we have a pretty indecisive close. This usually signals a reversal pattern (80% of the time)
So if you guys got a lot of calls, or long a lot of position, hedge yourself a bit with SPXS( bear etf) or some VXX.
I personally feel that we could go bearish with Covid wave 2 really surging and we also had a spike in unemployment( that means the economy wasn't recovering as well as we thought)
However, the bullish case is that the fed is still sitting on a lot of money that they could infuse still, i posted a news article update about it on last friday. message me if you need the link.
What is spy?
The investment seeks to provide investment results that, before expenses, correspond generally to the price and yield performance of the S&P 500® Index. The Trust seeks to achieve its investment objective by holding a portfolio of the common stocks that are included in the index (the âPortfolioâ), with the weight of each stock in the Portfolio substantially corresponding to the weight of such stock in the index.
$MRNA Presses for Resumption of Bull TrendMRNA shares have maintained a positive posture in terms of Ichimoku Cloud trend bearing, with plenty of room to go on the upside according to recent RSI peaks.
That said, this is a Biotech, which means technicals only indicate a small piece of the story, dwarfed by potential headlines still to come.
Moderna, Inc. (MRNA) - swing trade ideaModerna, Inc. (MRNA) – after 3 weeks of correction and consolidation period the stock broke out of a bullish pennant today and retested resistance in the 65 area which if broken in the coming days could lead to new momentum with the target in the 80-85 range. Initial stop loss 57.5.
$MRNA Symmetrical Wedge with bullish channelLooking at a possible bullish breakout via Symmetrical Wedge if market and news behave. Support between 47-51 and possible resistance between 65-70.
Your charts are wrong?Are you looking at Price changes? Moves over time? What is it you want to see...?
Stuck with Candles looking for patterns?
Renko Blocks
Henken-Ashi
Kagi
+$1837 today with 3/3 wins. ( COURSE COMING SOON!!! )Hi Guys,
Another easy day in the market with 3 for 3 wins. We are designing a trading course at the moment which will teach you how to go from zero knowledge to trading profitable in the chat room with us!
Enjoy,
Enda
Purchasing MRNA calls in June.May's monthly candle closed above April's high.
If price returns to April's high, then I will begin purchasing call options at the 56.00 strike with a July 2 expiration.
$MRNA$MRNA
Bullish falling wedge
Resistance: 65.16
Support: 47.56
Buy: $56.40
Stop loss: $50.99
Limit sell: $63.90
Notes:
Still feel sketch about their "Secondary offering" it tells shareholders that they are going to take a giant ass pile of cash and set it on fire. However, as will all offerings... someone has to make money so you can decide if it is worth a longer term hold. Does the 3x run up justify its price. They just got caught saying they had "positive results" on a 45 person study and then redacted those comments.
$MRNA Slides to Put Primary Trend Support Under FireMRNA may have seen a climax in trend strength on the gap run earlier this month when it leaked positive but vague vaccine data and then dropped a secondary on the market. We saw an RSI bear divergence after all-time high oscillator readings. And now, we are flirting with a primary trendline break.
SHORT MRNA $83.30Pretty Obvious that this is WAY beyond the BB std dev. for 4 days in a row and likely to revert to the mean of at least $60.
